[go: up one dir, main page]

MX2016016021A - Composicion farmaceutica para prevenir y tratar la demencia senil y su metodo de preparacion. - Google Patents

Composicion farmaceutica para prevenir y tratar la demencia senil y su metodo de preparacion.

Info

Publication number
MX2016016021A
MX2016016021A MX2016016021A MX2016016021A MX2016016021A MX 2016016021 A MX2016016021 A MX 2016016021A MX 2016016021 A MX2016016021 A MX 2016016021A MX 2016016021 A MX2016016021 A MX 2016016021A MX 2016016021 A MX2016016021 A MX 2016016021A
Authority
MX
Mexico
Prior art keywords
weight
parts
pharmaceutical composition
preparation
senile dementia
Prior art date
Application number
MX2016016021A
Other languages
English (en)
Other versions
MX376573B (es
Inventor
Ke Xiao
Hao Xiaofeng
Meng Baohua
Original Assignee
Sichuan Jishengtang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Jishengtang Pharmaceutical Co Ltd filed Critical Sichuan Jishengtang Pharmaceutical Co Ltd
Publication of MX2016016021A publication Critical patent/MX2016016021A/es
Publication of MX376573B publication Critical patent/MX376573B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripcion se refiere a una composicion farmaceutica para prevenir y tratar la demencia senil y su metodo de preparacion. Los ingredientes activos de la composicion farmaceutica se preparan a partir de materias primas medicinales que comprenden 20-50 partes en peso de Epimedii Folium y 15-55 partes en peso de Poria; o a partir de materias primas medicinales que comprenden 20-50 partes en peso de Epimedii Folium, 15-55 partes en peso de Poria y 10-55 partes en peso de Acanthopanax, o a partir de materias primas medicinales que comprenden 20-50 partes en peso de Epimedii Folium, 15-50 partes en peso de Poria, 15-50 partes en peso de Acanthopanax y 6-15 partes en peso de Anemarrhenae Rhizoma.
MX2016016021A 2014-06-20 2015-06-19 Composición farmacéutica para prevenir y tratar la demencia senil y su método de preparación. MX376573B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410280231 2014-06-20
PCT/CN2015/081950 WO2015192804A1 (zh) 2014-06-20 2015-06-19 一种预防和治疗老年痴呆的药物组合物及其制备方法

Publications (2)

Publication Number Publication Date
MX2016016021A true MX2016016021A (es) 2017-02-02
MX376573B MX376573B (es) 2025-03-07

Family

ID=54934892

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016021A MX376573B (es) 2014-06-20 2015-06-19 Composición farmacéutica para prevenir y tratar la demencia senil y su método de preparación.

Country Status (15)

Country Link
US (2) US10646536B2 (es)
EP (1) EP3159004B1 (es)
JP (1) JP6461320B2 (es)
KR (3) KR20170003700A (es)
CN (1) CN105311083B (es)
AU (1) AU2015276657B2 (es)
CA (1) CA2950638C (es)
ES (1) ES2774046T3 (es)
MX (1) MX376573B (es)
MY (1) MY187573A (es)
PE (1) PE20170199A1 (es)
PH (1) PH12016502302B1 (es)
RU (1) RU2671566C2 (es)
SG (1) SG11201609701UA (es)
WO (1) WO2015192804A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003700A (ko) 2014-06-20 2017-01-09 쓰촨 지쉔탕 파마슈티칼 코., 엘티디. 노인성 치매의 예방과 치료에 사용되는 의약 조성물 및 그 제조 방법
CN115120497B (zh) * 2021-05-14 2024-10-25 上海阶平医院管理有限公司 一种缓解老年痴呆用冷敷凝胶的制备装置及其制备方法
CN113491251B (zh) * 2021-07-02 2022-12-20 山西中医药大学 肾阳虚型帕金森病大鼠模型的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198336A (zh) 1997-05-06 1998-11-11 赵寿堂 一种健脑中成药
KR20050021026A (ko) 2001-06-15 2005-03-07 주식회사 장생도라지 장생도라지 추출물을 포함하는 면역계의 이상으로부터발생하는 질병의 예방 및 치료용 약제학적 조성물
FI112962B (fi) 2002-07-30 2004-02-13 Tamfelt Oyj Abp Paperikonekudos
CN100473413C (zh) 2006-03-14 2009-04-01 北京万寿通医药科技有限公司 一种治疗老年期痴呆的中药制剂
CN101229293A (zh) * 2008-01-14 2008-07-30 北京中科雍和医药技术有限公司 一种治疗老年期痴呆的药物组合物及其制备方法
CN101543576A (zh) 2008-03-28 2009-09-30 天科仁祥技术（北京）有限责任公司 一种预防及治疗老年性痴呆的药物组合及其制备方法
CN101417048A (zh) 2008-11-25 2009-04-29 山西省长治精神病院 一种治疗老年期精神病的中药
CN101780215B (zh) * 2009-01-19 2013-03-27 河北以岭医药研究院有限公司 一种含有人参的中药组合物水提液的精制方法
CN101574499A (zh) * 2009-06-05 2009-11-11 李振爽 安神宁心胶囊
CN101732660B (zh) * 2009-12-25 2011-10-19 卢速江 一种治疗前列腺疾病的中药制剂及其制备方法
CN101940703A (zh) 2010-08-11 2011-01-12 徐建 一种具有治疗和调整保健作用的酊剂
JP2012126716A (ja) 2010-11-26 2012-07-05 Kracie Seiyaku Kk 認知症の予防・治療に有効な組成物及びそれを含有する漢方・生薬製剤
CN103099833A (zh) 2011-11-14 2013-05-15 甘肃创兴生物工程有限责任公司 有助于缓解运动疲劳和延缓衰老的软胶囊及其制备方法
CN102698172B (zh) 2012-05-16 2014-05-14 江苏苏南药业实业有限公司 治疗老年痴呆症的药物组合物
KR20170003700A (ko) 2014-06-20 2017-01-09 쓰촨 지쉔탕 파마슈티칼 코., 엘티디. 노인성 치매의 예방과 치료에 사용되는 의약 조성물 및 그 제조 방법

Also Published As

Publication number Publication date
RU2016146370A (ru) 2018-07-20
US20200222491A1 (en) 2020-07-16
AU2015276657B2 (en) 2017-12-14
JP6461320B2 (ja) 2019-01-30
SG11201609701UA (en) 2016-12-29
MY187573A (en) 2021-09-30
RU2016146370A3 (es) 2018-07-20
PH12016502302A1 (en) 2017-02-13
CN105311083A (zh) 2016-02-10
MX376573B (es) 2025-03-07
US10646536B2 (en) 2020-05-12
CA2950638C (en) 2019-12-31
AU2015276657A1 (en) 2016-12-01
KR101990758B1 (ko) 2019-06-18
CN105311083B (zh) 2019-06-11
EP3159004A1 (en) 2017-04-26
US11278584B2 (en) 2022-03-22
PH12016502302B1 (en) 2022-03-23
KR20180099911A (ko) 2018-09-05
KR20180088532A (ko) 2018-08-03
RU2671566C2 (ru) 2018-11-02
KR20170003700A (ko) 2017-01-09
PE20170199A1 (es) 2017-04-08
CA2950638A1 (en) 2015-12-23
ES2774046T3 (es) 2020-07-16
JP2017515916A (ja) 2017-06-15
HK1221158A1 (zh) 2017-05-26
EP3159004A4 (en) 2018-02-21
US20170136083A1 (en) 2017-05-18
EP3159004B1 (en) 2020-01-29
WO2015192804A1 (zh) 2015-12-23

Similar Documents

Publication Publication Date Title
MX390064B (es) Formas cristalinas de mononucleotido de beta-nicotinamida.
BR112016000779A8 (pt) inibidores de autotaxina que compreendem núcleo do ciclo de benzilamida de anel heteroaromático, seus usos, composição e combinação farmacêuticas
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
MX387235B (es) Derivados de pirazolopiridina y su uso en terapia
DOP2016000226A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
BR112016025876A8 (pt) composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2
MD20170048A2 (ro) Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
CO2017000558A2 (es) Variantes de proteínas de unión al factor h
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
MX2014012742A (es) Composicion para el tratamiento de transtornos metabólicos.
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
MX2018013728A (es) Metodo de produccion de celastrol y derivados de triterpeno pentaciclicos.
BR112017006779A2 (pt) composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento
EA201590571A1 (ru) Составы на основе растений
MX2016016021A (es) Composicion farmaceutica para prevenir y tratar la demencia senil y su metodo de preparacion.
CO2018004665A2 (es) Compuestos oxadiazoespíricos
BR112016030728A2 (pt) método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
BR112016007031A8 (pt) composição farmacêutica oral sólida, processo para preparar a composição farmacêutica oral sólida, e uso de uma composição farcêutica oral sólida
TR201904585T4 (tr) Göz yorgunluğu ve rahatsızlığını bertaraf etmek ve hafifletmek için göz ferahlatıcı madde.
AR084195A1 (es) Formulacion de un complejo que comprende clorhidrato de lercanidipina y valsartan y metodo para la preparacion de la misma
BR112015020085A2 (pt) lipídeo que inibe a atividade do canal de nav1.9, composição, e kit
AR097111A1 (es) Combinación y método para la administración a un animal
PH12019500024A1 (en) Pharmaceutical compositions
BR112014032037A2 (pt) formulações para a preparação de comprimidos de liberação imediata para uso oral contendo uma baixa dosagem de mifepristona para o tratamento de endometriose, comprimidos desse modo obtidos e seu processo de preparação

Legal Events

Date Code Title Description
FG Grant or registration